ATE125268T1 - Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes. - Google Patents
Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes.Info
- Publication number
- ATE125268T1 ATE125268T1 AT89907392T AT89907392T ATE125268T1 AT E125268 T1 ATE125268 T1 AT E125268T1 AT 89907392 T AT89907392 T AT 89907392T AT 89907392 T AT89907392 T AT 89907392T AT E125268 T1 ATE125268 T1 AT E125268T1
- Authority
- AT
- Austria
- Prior art keywords
- acid
- binding protein
- protein
- insulin
- protein complex
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPI931488 | 1988-07-15 | ||
AUPJ335089 | 1989-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE125268T1 true ATE125268T1 (de) | 1995-08-15 |
Family
ID=25643507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89907392T ATE125268T1 (de) | 1988-07-15 | 1989-07-14 | Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5936064A (de) |
EP (1) | EP0424416B1 (de) |
JP (4) | JP3178714B2 (de) |
AT (1) | ATE125268T1 (de) |
CA (1) | CA1341598C (de) |
DE (1) | DE68923556T2 (de) |
HK (1) | HK206196A (de) |
WO (1) | WO1990000569A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991018622A1 (en) * | 1990-05-30 | 1991-12-12 | President And Fellows Of Harvard College | Wound healing |
WO1992003152A1 (en) * | 1990-08-28 | 1992-03-05 | Chiron Corporation | New insulin-like growth factor binding protein (igfbp-4) |
US5212074A (en) * | 1990-08-28 | 1993-05-18 | Chiron Corporation | Genetic material encoding new insulin-like growth factor binding protein igfbp-6 |
US6326154B1 (en) | 1990-11-19 | 2001-12-04 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
US5210017A (en) * | 1990-11-19 | 1993-05-11 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
FI86777C (fi) * | 1990-12-31 | 1992-10-12 | Medix Biochemica Ab Oy | Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid |
WO1992012243A1 (en) | 1991-01-08 | 1992-07-23 | Chiron Corporation | New insulin-like growth factor binding protein (igfbp-6) |
US5187151A (en) * | 1991-02-12 | 1993-02-16 | Genentech, Inc. | Use of binding protein with igf-i as an anabolic growth promoting agent |
FI94181C (fi) | 1992-06-29 | 1995-07-25 | Medix Biochemica Ab Oy | Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus |
WO1994010207A2 (en) | 1992-11-04 | 1994-05-11 | Chiron Corporation | Truncated insulin-like growth factor binding proteins having mitogenic activity |
EP0686040A1 (de) * | 1993-01-29 | 1995-12-13 | Amgen Boulder Inc. | Wunden heilende zusammensetzumg |
US5994302A (en) * | 1994-12-09 | 1999-11-30 | Human Genome Sciences, Inc. | Human vascular IBP-like growth factor |
US5747280A (en) * | 1995-06-05 | 1998-05-05 | Human Genome Sciences, Inc. | Human vascular IBP-like growth factor |
WO1997035196A1 (en) * | 1996-03-20 | 1997-09-25 | Dyax Corp. | Engineering affinity ligands for macromolecules |
GB2321191B (en) * | 1997-01-17 | 2000-09-27 | Johnson & Johnson Medical | Peptides for use in wound treatment |
AUPR030900A0 (en) | 2000-09-22 | 2000-10-12 | Queensland University Of Technology | Growth factor complex |
US6875570B2 (en) | 2000-09-27 | 2005-04-05 | Curagen Corporation | Proteins and nucleic acids encoding same |
WO2002026826A2 (en) * | 2000-09-27 | 2002-04-04 | Curagen Corporation | Proteins and nucleic acids encoding same |
US7153691B2 (en) * | 2002-11-13 | 2006-12-26 | G6 Science Corp. | Method of identifying and assessing DNA euchromatin in biological cells for detecting disease, monitoring wellness, assessing bio-activity, and screening pharmacological agents |
US20100143442A1 (en) | 2003-02-05 | 2010-06-10 | Queensland University Of Technology | Growth factor complexes and modulation of cell migration and growth |
WO2011063477A1 (en) | 2009-11-30 | 2011-06-03 | Queensland University Of Technology | Fibronectin: growth factor chimeras |
AU2003900481A0 (en) | 2003-02-05 | 2003-02-20 | Queensland University Of Technology | Synthetic modulators of cell migration and growth |
AU2003903896A0 (en) | 2003-07-28 | 2003-08-07 | Queensland University Of Technology | Skin regeneration system |
WO2005033132A2 (en) | 2003-10-03 | 2005-04-14 | Genentech, Inc. | Igf binding proteins |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2648951B2 (ja) * | 1987-04-06 | 1997-09-03 | セルトリックス ファーマシュウティカルズ,インク | 人体のソマトメジン担体蛋白質サブユニットとこれらの製法 |
DK131988A (da) * | 1988-03-11 | 1989-09-12 | Erasmus University | Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur |
US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
JPH03504597A (ja) * | 1988-04-12 | 1991-10-09 | シナージェン,インコーポレーテッド | インスリン様成長因子活性の強化および阻害方法 |
US5324820A (en) * | 1988-07-15 | 1994-06-28 | Central Sydney Area Health Service | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
US5258257A (en) * | 1991-09-23 | 1993-11-02 | Shipley Company Inc. | Radiation sensitive compositions comprising polymer having acid labile groups |
-
1989
- 1989-07-14 CA CA000605669A patent/CA1341598C/en not_active Expired - Fee Related
- 1989-07-14 EP EP89907392A patent/EP0424416B1/de not_active Expired - Lifetime
- 1989-07-14 DE DE68923556T patent/DE68923556T2/de not_active Expired - Lifetime
- 1989-07-14 WO PCT/AU1989/000299 patent/WO1990000569A1/en active IP Right Grant
- 1989-07-14 AT AT89907392T patent/ATE125268T1/de not_active IP Right Cessation
- 1989-07-14 JP JP50767289A patent/JP3178714B2/ja not_active Expired - Lifetime
-
1995
- 1995-06-02 US US08/459,209 patent/US5936064A/en not_active Expired - Fee Related
-
1996
- 1996-11-14 HK HK206196A patent/HK206196A/xx not_active IP Right Cessation
-
2001
- 2001-01-26 JP JP2001018464A patent/JP2001252087A/ja active Pending
-
2003
- 2003-05-21 JP JP2003143508A patent/JP2003319791A/ja active Pending
-
2005
- 2005-01-05 JP JP2005000697A patent/JP2005118052A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2005118052A (ja) | 2005-05-12 |
HK206196A (en) | 1996-11-22 |
WO1990000569A1 (en) | 1990-01-25 |
EP0424416B1 (de) | 1995-07-19 |
EP0424416A4 (en) | 1992-03-18 |
JP2001252087A (ja) | 2001-09-18 |
JP3178714B2 (ja) | 2001-06-25 |
CA1341598C (en) | 2009-09-29 |
JPH03506030A (ja) | 1991-12-26 |
DE68923556T2 (de) | 1996-04-11 |
JP2003319791A (ja) | 2003-11-11 |
EP0424416A1 (de) | 1991-05-02 |
DE68923556D1 (de) | 1995-08-24 |
US5936064A (en) | 1999-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE125268T1 (de) | Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein- komplexes. | |
DE3851153D1 (de) | Genetische modifizierung von endothelialen zellen. | |
ATE403713T1 (de) | Stamzellfaktor | |
ES2009590A6 (es) | Metodo de preparacion de proteina de cadena pesada del factor tisular humano. | |
LU91237I2 (fr) | Palifermin et ses dérivés pharmaceutiquement acceptables (kepivance) | |
IL154797A0 (en) | Vascular endothelial cell growth factor that is unaccompanied by associated native glycosylation, pharmaceutical composition containing it and use thereof in the manufacture of a medicament for treating trauma affecting the vascular endothelium | |
ES2094159T3 (es) | Produccion de factor de crecimiento de celulas endoteliales vasculares. | |
HK166495A (en) | HIV-1 envelope muteins lacking hypervariable domains | |
DE69034091D1 (de) | Herstellung von Hämoglobin und Analogen davon in Nicht-Erythrozytzellen | |
ATE76878T1 (de) | Solubilisierung von protein-aggregaten. | |
ATE423788T1 (de) | Neues tgf-beta-ahnliches cytokin | |
EP0216742A3 (de) | Wachstumsfaktoren | |
DE3650135T2 (de) | Proteingewinnung. | |
KR900002795A (ko) | 하이브리드 단백질c 작제물 및 그들의 제조방법 | |
BR9509172A (pt) | Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica | |
FR2662698B1 (de) | ||
DE69330352T2 (de) | Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut | |
DE69102651D1 (de) | Proteaseresistenter pdgf und dessen verwendungen. | |
ES2138973T3 (es) | Muteinas de il-6 exentas de cisteina. | |
ES2004099A6 (es) | Procedimiento de preparacion de polipeptidos biologicamente activos | |
EP0315118A3 (de) | Endothelin kodierendes DNA und dessen Verwendung | |
ES8600518A1 (es) | Metodo in vitro para detectar un estado maligno en un paciente humano. | |
GB9401689D0 (en) | Diagnosis and treatment of endocarditis | |
KR910007963A (ko) | pST의 일부분에 대응하는 아미노산 서열을 갖는 펩티드, 그에 대한 항체 및 pST 활성에 효력을 더하는 방법 | |
FI885025A (fi) | Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |